Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumbrokinase in Moderate-to-Severe Ischemic Stroke
NCT07763405Phase 4Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 4 trial of lumbrokinase in ischemic stroke, sponsored by Xinqiao Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
lumbrokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07763405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763405.